BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32763337)

  • 1. NOTCH pathway activation in infantile hemangiomas.
    Zhang H; Wei T; Johnson A; Sun R; Richter G; Strub GM
    J Vasc Surg Venous Lymphat Disord; 2021 Mar; 9(2):489-496. PubMed ID: 32763337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A switch in Notch gene expression parallels stem cell to endothelial transition in infantile hemangioma.
    Wu JK; Adepoju O; De Silva D; Baribault K; Boscolo E; Bischoff J; Kitajewski J
    Angiogenesis; 2010 Mar; 13(1):15-23. PubMed ID: 20069356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A potential role for notch signaling in the pathogenesis and regulation of hemangiomas.
    Wu JK; Kitajewski JK
    J Craniofac Surg; 2009 Mar; 20 Suppl 1(0 1):698-702. PubMed ID: 19169152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propranolol Targets Hemangioma Stem Cells via cAMP and Mitogen-Activated Protein Kinase Regulation.
    Munabi NC; England RW; Edwards AK; Kitajewski AA; Tan QK; Weinstein A; Kung JE; Wilcox M; Kitajewski JK; Shawber CJ; Wu JK
    Stem Cells Transl Med; 2016 Jan; 5(1):45-55. PubMed ID: 26574555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propranolol induces regression of hemangioma cells via the down-regulation of the PI3K/Akt/eNOS/VEGF pathway.
    Pan WK; Li P; Guo ZT; Huang Q; Gao Y
    Pediatr Blood Cancer; 2015 Aug; 62(8):1414-20. PubMed ID: 25728347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of β-Adrenergic Receptor Subtypes in Proliferative, Involuted, and Propranolol-Responsive Infantile Hemangiomas.
    Phillips JD; Zhang H; Wei T; Richter GT
    JAMA Facial Plast Surg; 2017 Mar; 19(2):102-107. PubMed ID: 27737446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pigment epithelium-derived factor/vascular endothelial growth factor ratio plays a crucial role in the spontaneous regression of infant hemangioma and in the therapeutic effect of propranolol.
    Zhu L; Xie J; Liu Z; Huang Z; Huang M; Yin H; Qi W; Yang Z; Zhou T; Gao G; Zhang J; Yang X
    Cancer Sci; 2018 Jun; 109(6):1981-1994. PubMed ID: 29664206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferative hemangiomas: analysis of cytokine gene expression and angiogenesis.
    Chang J; Most D; Bresnick S; Mehrara B; Steinbrech DS; Reinisch J; Longaker MT; Turk AE
    Plast Reconstr Surg; 1999 Jan; 103(1):1-9; discussion 10. PubMed ID: 9915157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is Infantile Hemangioma a Neuroendocrine Tumor?
    Kaulanjan-Checkmodine P; Oucherif S; Prey S; Gontier E; Lacomme S; Loot M; Miljkovic-Licina M; Cario M; Léauté-Labrèze C; Taieb A; Moisan F; Rezvani HR
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of signaling systems in proliferating and involuting phase infantile hemangiomas by genome-wide transcriptional profiling.
    Calicchio ML; Collins T; Kozakewich HP
    Am J Pathol; 2009 May; 174(5):1638-49. PubMed ID: 19349369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and immunohistochemical expression of apoptotic proteins Bax, Bcl-2 and Caspase 3 in infantile hemangioma tissues as an effect of propranolol treatment.
    Wnęk A; Andrzejewska E; Kobos J; Taran K; Przewratil P
    Immunol Lett; 2017 May; 185():27-31. PubMed ID: 28279700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of estrogen and progesterone receptors in proliferating and involuting infantile hemangiomas.
    Johnson A; Zhang H; Gonzalez SR; Lee M; Wei T; Richter G
    J Plast Reconstr Aesthet Surg; 2021 Nov; 74(11):3061-3065. PubMed ID: 34011473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and economic impact of surgery for treating infantile hemangiomas in the era of propranolol: overview of single-center experience from La Paz Hospital, Madrid.
    López-Gutiérrez JC
    Eur J Pediatr; 2019 Jan; 178(1):1-6. PubMed ID: 30421264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A further experience of propranolol for severe infantile hemangiomas of the face: an observational study.
    Greco A; D'Erme AM; Zamma Gallarati B; Caputo R; de Martino M
    Dermatol Ther; 2014; 27(4):198-202. PubMed ID: 24548454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of LIN28B/Let-7 Signaling by Propranolol Contributes to Infantile Hemangioma Involution.
    Mong EF; Akat KM; Canfield J; Lockhart J; VanWye J; Matar A; Tsibris JCM; Wu JK; Tuschl T; Totary-Jain H
    Arterioscler Thromb Vasc Biol; 2018 Jun; 38(6):1321-1332. PubMed ID: 29724816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infantile hemangioma-mechanism(s) of drug action on a vascular tumor.
    Greenberger S; Bischoff J
    Cold Spring Harb Perspect Med; 2011 Sep; 1(1):a006460. PubMed ID: 22229118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of renin-angiotensin-aldosterone axis components in infantile hemangioma tissue and the impact of propranolol treatment.
    Dornhoffer JR; Wei T; Zhang H; Miller E; A Cleves M; Richter GT
    Pediatr Res; 2017 Jul; 82(1):155-163. PubMed ID: 28376078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Thrombospondin-1 and Nuclear Factor-κB Signaling Pathways in Antiangiogenesis of Infantile Hemangioma.
    Xu W; Li S; Yu F; Zhang Y; Yang X; An W; Wang W; Sun C
    Plast Reconstr Surg; 2018 Sep; 142(3):310e-321e. PubMed ID: 30148773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of propranolol on the biology and Notch signaling pathway of human umbilical vein endothelial cells.
    Chen S; Zhao X; Huang J; Lin N; Xu Q; Chen J; Huang J; Wang L; Lin C; Zhang Z
    Medicine (Baltimore); 2023 Aug; 102(32):e34672. PubMed ID: 37565874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infantile hemangiomas, complications and treatments.
    Cheng CE; Friedlander SF
    Semin Cutan Med Surg; 2016 Sep; 35(3):108-16. PubMed ID: 27607318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.